Filters

Zolmitriptan manufacturers

Filters

Filters

Filters , active

Country of origin : India
None products found

zolmitriptan

Tablets, orally disintegrating (ODT) 2.5 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Manufacturer #23786
Founded in the 1950s with nearly seven decades of pharmaceutical leadership, this integrated pharma company is among the top players in its home market. Rx and OTC portfolio spans branded generics, biosimilars, APIs, and novel drugs across oncology, metabolic, cardiac, and infectious disease therapy areas. US FDA and EU-GMP approved facilities operate across multiple continents.

Manufacturer usually replies in 9 days

zolmitriptan

Tablets 2.5 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Manufacturer #23786
Founded in the 1950s with nearly seven decades of pharmaceutical leadership, this integrated pharma company is among the top players in its home market. Rx and OTC portfolio spans branded generics, biosimilars, APIs, and novel drugs across oncology, metabolic, cardiac, and infectious disease therapy areas. US FDA and EU-GMP approved facilities operate across multiple continents.

Manufacturer usually replies in 9 days

zolmitriptan

Tablets 2.5 mg, 5 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Unavailable markets
Czech Republic , Germany , Netherlands , Poland , Romania , Slovakia , Spain , United Kingdom
Comments
DCP approved
Manufacturer #6978
This global pharmaceutical company specializes in branded and generic medications, offering a wide range of products across various therapeutic areas including dermatology, oncology, and respiratory therapy. They prioritize quality manufacturing with GMP certifications and hold several patents for their innovative drug formulations. The company boasts a strong global presence spanning North America, Europe, Asia, Africa, Latin America, and the Middle East, with multiple manufacturing facilities strategically located in key regions. Their commitment to research and development is evident through dedicated R&D centers focused on advancing therapies and improving patient care worldwide.

Manufacturer usually replies in 42 days

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription
Zolmitriptan is a medication used to treat severe migraines. Suppliers of zolmitriptan market it in the form of 2.5mg and 5mg tablets, as well as nasal sprays. Alternatives to zolmitriptan are other triptan class medications, namely, sumatriptan, naratriptan, rizatriptan, almotriptan, eletriptan, and frovatriptan. The drug was first introduced into the pharmaceutical market in 1997 and has since then become approved in over 100 countries globally, including but not limited to geographical markets China, Australia, Japan, Brazil, as well as across Europe. The largest manufacturers and suppliers of zolmitriptan medications are companies Sun Pharmaceuticals, Teva, and AstraZeneca. Following patent expiry in 2013, other manufacturers launched their generic formulations of zolmitriptan. Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified zolmitriptan manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform. Retail prices for 6 (2.5mg) tablets of zolmitriptan are approximately 30 EUR to 40 EUR.

Willing to unlock more features?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.